# 4-Point Therapy Response Score With PET/CT for Anal Squamous Cell Cancer

> **NCT05130073** · — · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 41 (actual)

## Conditions studied

- Anal Squamous Cell Carcinoma
- Stage 0 Anal Cancer AJCC v8
- Stage I Anal Cancer AJCC v8
- Stage II Anal Cancer AJCC v8
- Stage IIA Anal Cancer AJCC v8
- Stage IIB Anal Cancer AJCC v8
- Stage III Anal Cancer AJCC v8
- Stage IIIA Anal Cancer AJCC v8
- Stage IIIB Anal Cancer AJCC v8
- Stage IIIC Anal Cancer AJCC v8

## Interventions

- **PROCEDURE:** Computed Tomography
- **OTHER:** Electronic Health Record Review
- **PROCEDURE:** Follow-Up
- **PROCEDURE:** Positron Emission Tomography

## Key facts

- **NCT ID:** NCT05130073
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-31
- **Primary completion:** 2023-12-14
- **Final completion:** 2023-12-14
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2024-02-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05130073

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05130073, "4-Point Therapy Response Score With PET/CT for Anal Squamous Cell Cancer". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT05130073. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*